Literature DB >> 31753253

Drug-Induced Liver Injury in the Setting of Chronic Liver Disease.

Nicholas A Hoppmann1, Meagan E Gray2, Brendan M McGuire2.   

Abstract

Drug-induced liver injury (DILI) is an uncommon but significant cause of liver injury and need for liver transplant. DILI in the setting of chronic liver disease (CLD) is poorly understood. Clinical features of patients presenting with DILI in the setting of CLD are similar to those without CLD with the exception of a higher incidence of diabetes among those with CLD and DILI. Diagnosis of DILI in CLD is difficult because there are no objective biomarkers and current causality assessments have not been studied in this population. Differentiating DILI from exacerbation of underlying liver disease is even more challenging.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute-on-chronic liver failure; Chronic liver disease; Drug-induced liver injury; Hepatotoxicity

Mesh:

Year:  2019        PMID: 31753253     DOI: 10.1016/j.cld.2019.09.006

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  1 in total

1.  Establishment of a Stable Acute Drug-Induced Liver Injury Mouse Model by Sodium Cyclamate.

Authors:  Quan Zhou; Zhongtian Peng; Xialing Huang
Journal:  J Inflamm Res       Date:  2022-03-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.